Search
Adekalant
go.drugbank.com/drugs/DB20077ExperimentalAdekalant is a small molecule drug. The usage of the INN stem '-kalant' in the name indicates that Adekalant is a potassium channel blocker. Adekalant has a monoisotopic molecular weight of 401.23 Da.
Eclazolast
go.drugbank.com/drugs/DB21130ExperimentalEclazolast is a small molecule drug. The usage of the INN stem '-zolast' in the name indicates that Eclazolast is a leukotriene biosynthesis inhibitor.
Nifurfoline
go.drugbank.com/drugs/DB21198ExperimentalNifurfoline is a small molecule drug. The usage of the INN stem 'nifur-' in the name indicates that Nifurfoline is a 5-nitrofuran derivative.
Lapisteride
go.drugbank.com/drugs/DB21206ExperimentalLapisteride is a small molecule drug. The usage of the INN stem '-steride' in the name indicates that Lapisteride is a androgen/anabolic steroid.
Nifurvidine
go.drugbank.com/drugs/DB21393ExperimentalNifurvidine is a small molecule drug. The usage of the INN stem 'nifur-' in the name indicates that Nifurvidine is a 5-nitrofuran derivative.
Nivasorexant
go.drugbank.com/drugs/DB21506ExperimentalNivasorexant is a small molecule drug. The usage of the INN stem '-orexant' in the name indicates that Nivasorexant is a orexin receptor antagonist.
Dalmelitinib
go.drugbank.com/drugs/DB21538ExperimentalDalmelitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Dalmelitinib is a tyrosine kinase inhibitor.
Funobactam
go.drugbank.com/drugs/DB21541InvestigationalFunobactam is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Funobactam is a ẞ-lactamase inhibitor. Funobactam has a monoisotopic molecular weight of 399.1 Da.
Atinvicitinib
go.drugbank.com/drugs/DB21558ExperimentalAtinvicitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Atinvicitinib is a Janus kinase inhibitor.
Fulimetibant
go.drugbank.com/drugs/DB21599ExperimentalFulimetibant is a small molecule drug. The usage of the INN stem '-tibant' in the name indicates that Fulimetibant is a bradykinin receptor antagonist.